Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50357895 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_787640 (CHEMBL1918093) | ||
IC50 | 422±n/a nM | ||
Citation | Lumeras, W; Vidal, L; Vidal, B; Balagué, C; Orellana, A; Maldonado, M; Domínguez, M; Segarra, V; Caturla, F 1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase. J Med Chem54:7899-910 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50357895 | |||
n/a | |||
Name | BDBM50357895 | ||
Synonyms: | CHEMBL1916352 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H25F2N3O3 | ||
Mol. Mass. | 477.5025 | ||
SMILES | Cc1cc(OCCN2CCOCC2)ccc1-c1[n+]([O-])ccc2c(ccnc12)-c1ccc(F)cc1F |(39.03,-36.8,;37.7,-37.57,;37.71,-39.11,;36.38,-39.89,;36.38,-41.43,;35.05,-42.2,;33.71,-41.44,;32.38,-42.21,;31.05,-41.44,;29.73,-42.21,;29.72,-43.75,;31.06,-44.52,;32.4,-43.75,;35.04,-39.12,;35.04,-37.58,;36.37,-36.81,;36.37,-35.28,;35.03,-34.51,;33.7,-35.28,;35.04,-32.96,;36.37,-32.19,;37.7,-32.96,;39.03,-32.18,;40.37,-32.96,;40.37,-34.51,;39.03,-35.27,;37.7,-34.5,;39.03,-30.65,;37.7,-29.88,;37.7,-28.35,;39.04,-27.57,;39.04,-26.03,;40.37,-28.34,;40.37,-29.88,;41.7,-30.65,)| | ||
Structure |